Condition
Viral Suppression of HIV Infection
Total Trials
2
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
4 treatments under study, led by The Dosage Of 400mg Efv
Research Leaders
7 sponsors active, led by National Center for AIDS/STD Control and Prevention, China CDC
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting1
Unknown1
Clinical Trials (2)
Research Network
Common Treatments
- The Dosage Of 400mg Efv1
- Restart Objective Adherence Selfmonitoring And Postive Affect Mhealth Intervention1
- Personal Involved Intervention Strategies1
- Urine Tenofovir Pointofcare Selftest1
Active Sponsors
- National Center for AIDS/STD Control and Prevention, China CDC1
- University of California, San Francisco1
- Yunnan AIDS Care Center1
- Yunnan Center for Disease Control and Prevention1
- National Institute on Drug Abuse (NIDA)1
Top Investigators
National Center for AIDS/STD Control and Prevention
University of California, San Francisco
Related Conditions
- Art Adherence1
- Behavioral Intervention1